AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in US
AZN beats third-quarter estimates for earnings and sales. It raises its sales and profit outlook for 2024 for the second…
78,250€
0,97%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off
AstraZeneca Plc started the week with a market valuation of about £171 billion ($222 billion). By the close on Thursday…
AstraZeneca: Contrarian Buy After The China Challenge (Rating Upgrade)
…
AstraZeneca Says Current, Former Executives Involved in China Probe
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe…
AstraZeneca Aktie: Kursrückgang übertrieben
Toronto (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von BMO Capital Markets:
1. Überblick über die Situation
AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London…